Search results for: “oncology”
-
SubjectWell acquires PatientCentra to expand global patient recruitment services
•
PARIS: SubjectWell, a platform that connects patients with chronic conditions to new treatments, has announced that it has…
-
AstraZeneca and Cellectis partner to accelerate development of next-generation therapeutics
•
LONDON, UK: AstraZeneca (NYSE: AZN) today announced a collaboration and investment agreement with Cellectis (NASDAQ: CLLS), a clinical-stage…
-
Bristol-Myers Squibb to acquire Mirati Therapeutics for up to $5.8 billion
•
Bristol-Myers Squibb (BMY.N) announced on Sunday that it has agreed to buy Mirati Therapeutics (MRTX.O), a cancer drugmaker…
-
AI drug discovery startup Noetik secures $14 million in seed funding
•
SAN FRANCISCO: Noetik, a pioneering AI drug discovery company headquartered in San Francisco, has achieved a significant milestone…
-
BCAL Diagnostics appoints Shane Ryan as COO
•
SYDNEY, AUSTRALIA: BCAL Diagnostics Limited, an Australian biotech company developing a blood test for breast cancer, has announced…
-
EUROAPI acquires Biano, a CDMO specialized in oligonucleotides
•
PARIS, FRANCE: EUROAPI, a leading European producer of active pharmaceutical ingredients, has announced that it has signed an…
-
OCTP announces breakthrough in cancer immunotherapy
•
LONDON, UK: Oxford Cannabinoid Technologies Holdings plc (OCTP), a leading pharmaceutical company in the field of cannabinoid medicines,…
-
Nanobiotix signs deal with Janssen for cancer drug NBTXR3
•
PARIS, FRANCE: Nanobiotix, a biotechnology company developing nanotherapeutics for cancer, has announced a global deal with Janssen Pharmaceutica…
-
Bitterroot Bio emerges from stealth with $145M to develop immunotherapies for heart disease
•
Bitterroot Bio, a biotech company that aims to develop immunotherapies for cardiovascular disease, has announced its emergence from…
-
Imagion Biosystems appoints Dr. Isaac Bright as CEO to drive next phase of growth
•
Melbourne, Australia: Imagion Biosystems (ASX: IBX), a leading healthcare company focused on early cancer detection, is thrilled to…
-
Avacta Group acquires Coris Bioconcept to expand diagnostics business
•
LONDON, UK: Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful…
-
Antisense Therapeutics Limited appoints Dr James Garner as CEO and MD
•
SYDNEY, AUSTRALIA: The Board of Directors of Antisense Therapeutics Limited announced the appointment of Dr James Garner MBBS…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.